• Recognize the diagnostic criteria of common cystic pancreatic neoplasms.
lined by the typical cellular elements are present. 5 Mitoses are conspicuously absent. 5 The surrounding stroma is uniformly dense and fibrous with areas of hyalinization. Dystrophic calcifications also can be present, as well as cholesterol clefts and hemosiderin-laden macrophages. Islets of Langerhans, scattered pancreatic acini, and nerves may also be seen.
Immunohistochemical studies are essentially of no value, with the epithelioid lining positive for CK7, 18, and 19, as well as focally for CA19.9, but characteristically negative for CEA. 5 
Variants of Pancreatic Serous Cystadenoma
Serous oligocystic adenoma is much less common than the microcystic variant. 6, 11 Notably, there is no sex predilection. The tumor has been seen in pediatric populations. 17 Most serous oligocystic adenomas are located in the head and the body of the pancreas, where they can obstruct the periampullary portion of the common bile duct. 17 A noncystic variant, "solid" serous adenoma, has been recognized. 13 The solid variant is believed to be small, ranging between 2 and 4 cm in greatest dimension. Differential diagnosis, because of the compact arrangements of small acini with a limited or no lumen and clear cytoplasm, include "sugar" tumor of the pancreas and metastatic renal cell carcinoma, as well as pancreatic endocrine tumors with clear cell.
Serous cystadenocarcinoma
Rare examples of malignant cystic neoplasm composed of glycogen-rich cells have been reported. Those patients presented with symptoms ranging from bleeding of gastric varices to invasion of the stomach and splenic vein, jaundice, and palpable abdominal masses.
The size of these tumors varies between 2.5 and 12 cm. On gross section, the neoplasms maintain a spongy appearance.
The histologic appearance is deceptively benign, with a marked resemblance to the benign counterpart, although mild focal nuclear pleomorphism can be found. Perineural invasion, vascular and perivascular invasion, and lymph node metastasis have been reported. Those lesions are slow-growing and compatible with prolonged survival.
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM Definition, Epidemiology and Etiology:
Intraductal papillary mucin-producing neoplasms (IPMNs) are composed of papillary proliferations of neoplastic mucin secretory cells that arise in the main pancreatic duct or its major branches. 16 IPMNs are usually diagnosed in adults with a median age at diagnosis in the sixth to seventh decade and a mean age of 68 years. 2, 15, 25, 34 The actual incidence of IPMN is not precisely known. The recent increase in diagnosis has paralleled the wider use of sophisticated imaging modalities. It is likely that many lesions diagnosed currently may have been undiagnosed in the past. IPMNs have been estimated to amount to about 1 to 3% of exocrine pancreatic neoplasms, with an incidence rate of less than 1 per 100,000. 23 
Clinical features:
The clinical presentation is varied, including epigastric pain, pancreatitis, weight loss, diabetes, and jaundice. However, many small and asymptomatic cases are found during CT scans done for other reasons. 17, 32, 36 Another feature usually diagnostic of this lesion is the abundant mucin extrusion from the ampulla of Vater, although it is not always recognized. A patulous ampullary opening was reported in 55% of the patients in one series. 8, 35 In practice, endoscopic ultrasound, ERCP, and CT scan, sometimes associated with cytologic examination and examination of fluid biochemical content, frequently lead to a preoperative diagnosis. 10, 33 Gross Pathology:
Most IPMNs arise in the main pancreatic duct and its branches in the head of the pancreas. 7, 13, 29 It may be unifocal or diffusely involve the duct or multifocal. 19, 27, 32 Multicentricity has been suspected because of recurrence in pancreatic remnants following surgical removal of IPMN. 18 The reported size of IPMN varies from about 1 cm to over 10 cm. However, the dimension is difficult to evaluate, given that the measurements also may include secondary cystic distension of ducts that are not involved by the tumor per se. 1 The distended duct(s) is/are filled by a usually sticky or viscous pale yellowish material which may be difficult to remove. The mucosal lining may appear smooth and glistening or granular and reflecting papillary growth. In some cases (up to 35%, according to some), a small focus of adenocarcinoma may be identified. 8, 11, 14, 18, 24, 26, 34 Histopathology:
The distended ductal structures are lined by papillary epithelium that may be divided into three categories based on the degree of atypia: Benign (adenoma), borderline, and malignant (either invasive or noninvasive). 16 In addition, emphasis has been placed recently on the recognition of two different types of mucinous epithelium.
The first, gastric/foveolar, usually shows low grade dysplasia (adenoma). The intestinal type resembles the colonic epithelium of villous adenomas 2 although in fact it usually is combined with epithelium also resembling gastric foveolar. It may show typical goblet cells and display moderate to high grade dysplasia. 16 The third histologic type is the pancreaticobiliary type. It is characterized by a higher degree of architectural complexity and composed of small cuboidal cells with higher nuclear atypia. 16 Goblet and Paneth cells may be present as a manifestation of intestinal metaplasia. Neuroendocrine cells also can be noted. 16 An oncocytic variant, IPMN, also has been described. 22, 30 This variant is rare and presents grossly with an appearance similar to typical IPMN. The lining epithelium is composed of stratified oncocytic cells with pale pink cytoplasm granules and sometimes scattered goblet cells. A characteristic feature of oncocytic IPMN is the formation of intraepithelial lumina. The clinical history appears similar to typical IPMNs.
Grading of IPMN: IPMNs should be graded in three groups: adenoma, borderline, or carcinoma invasive or noninvasive. In adenoma, the epithelium shows simple mucin-secreting cells with low N/C ratio, minimal cytologic atypia, and no or limited stratification. Borderline lesions are characterized by increased nuclear atypia, stratification of nuclei, and hyperchromicity. IPMN with carcinoma in situ demonstrates a significant nuclear atypia with prominent nucleoli, loss of mucin, and loss of nuclear polarity. Intraepithelial, micropapillary, and cribiform architecture also can be seen.
About 35% of IPMNs are associated with invasive adenocarcinoma. 28 The invasive neoplasm can be a typical ductal adenocarcinoma, although recent evidence suggests that a significant number of those cancers are colloid-type carcinomas, which have been associated with a better prognosis. 3, 4 Immunohistochemical characteristics:
Much interest has been taken recently in the evaluation of mucin expression as evidence of differentiation and as a marker of progression. 5, 20 The intestinal type is associated with MUC2 expression and not MUC1 (92% and 8% respectively), while the pancreaticobiliary type (seen only in a minority of cases) shows a lesser degree of MUC2 expression (19%) but often shows MUC1 immunolabeling (44%) The gastric type is positive for MUC5AC. 5, 20 Interestingly, in the same series, a significant number of the cases were "null" for MUC1 and MUC2. The significance of these findings remains to be elucidated with regard to prognostication of patients.
Genetic susceptibility:
Some have reported excessive rates of colonic and gastric epithelial neoplasm in patients with IPMN, although no specific hereditary syndrome has been identified initially. 9 However, two cases of IPMNs have been reported, in two males with well documented histories of FAP. In one of the patients, genetic analysis demonstrated loss of the wild allele of the APC gene in IPMT with inactivation of both alleles, thus suggesting that IPMT may represent an extracolonic localization of FAP. 12, 21 Prognosis:
The overall five-year survival rate is good compared to other pancreatic neoplasm (60 to 83% at five years). 9, 34 The prognosis is excellent for adenoma and borderline tumor with a five-year survival approaching 100%, provided that appropriate sampling has eliminated concurrent adenocarcinoma.
The survival is high for IPMN with noninvasive carcinoma, and some series have suggested that even for patients with invasive IPMN, the prognosis may be higher compared to typical ductal adenocarcinoma. 8, 34, 36 Colloid carcinoma, a variant which may be more frequently associated with IPMN, is also associated with a better prognosis. 3, 4, 6 Side branch intraductal papillary mucin-producing neoplasms Smaller cystic pancreatic lesions are now detected and some of them correspond to IPMNs that involve pancreatic side branches but spare the main pancreatic duct. Side branch IPMN is a controversial area with regard to its origin and prognosis. It has been reported by some that the prognosis is better with a lesser chance of malignant transformation. 31 According to one series, IPMN of the branch type corresponds to 30% of the cases. Patients with side branch IPMN were younger and the lesion were frequently located in the head and neck of the pancreas. The size of the cysts can range from 4 to 55 mm, and the major duct showed a mild dilation in most cases. Side branch IPMN were classified as adenoma (39%), borderline (46%) and in situ carcinoma (15%). No invasive carcinoma was observed. In contrast, main pancreatic duct type IPMNs showed invasive carcinoma and in situ carcinoma in 37% of the cases, thus suggesting that side branch IPMN may represent a distinctive group. 31 Mucinous cystic neoplasm (MCN), which occurs almost exclusively in women, presents as a cystic neoplasm devoid of communication with the ductal system and lined with tall columnar mucin-producing epithelium supported by ovariantype stroma. 5 The mean age of diagnosis is usually in the 5th decade of life (range: 20 to 82). 8 Given the changes in criteria (ovarian-type stroma), MCNs are probably rarer than initially believed. It is also likely that many cases reported in older series, as well as in men, were instead intraductal papillary mucinous neoplasms. 3, 9, 14 The etiology of MCN is not understood. The possibility that the stromal component of MCN is derived from ovarian primordium is supported by morphologic similarities with the possibility of undergoing luteinization, the presence of hilar-like cells, and immunophenotypic sex cord-stromal differentiation. The possibility that MCN arises from ectopic ovarian stroma incorporated during embryogenesis is supported by the fact that the primordial gonad and dorsal pancreatic anlage lie side by side during the fourth to fifth weeks of development. 5, 14 Clinical features:
Large tumors may produce vague symptoms related to the compression of adjacent organs, and may sometimes be palpable. Alternatively, smaller lesions are usually found incidentally. Mucinous cystic neoplasms are rarely associated with jaundice. Notably, an association with diabetes mellitus is relatively frequent. 8 Increase in serum CA19.9, as well in the cyst fluid, is also suggestive of mucinous cystic neoplasm. Also, among various imaging modalities, endoscopic retrograde cholangiography (ERCP) is cardinal in showing the absence of communication between the cystic cavity and the main pancreatic duct and its displacement. 8
Gross pathology:
MCNs have a predilection for the body and tail of the pancreas. They usually present as a round tumor with a smooth surface and fibrous capsule on section. Calcification can be observed. The size of the tumor ranges from 2 to 35 cm, with most measuring between 6 and 10 cm. 8 The cut surface demonstrates either unilocular or multilocular tumor with cystic spaces varying in size and thick mucin material. The lining of unilocular tumors is usually smooth and glistening, whereas small papillary projections and mural nodules can be seen in multilocular MCNs. Of note, malignant MCNs are likely to show papillary projections, mural nodules, and multilocularity. 5, 14 As a rule, there is no communication between mucinous cystic neoplasms and the pancreatic duct system, although exceptions have been reported. 14 
Histopathology
MCNs are characterized by two distinct histologic components: An epithelial inner layer composed of tall mucin-secreting epithelium, and dense cellular ovarian-type stroma.
The columnar mucin-producing epithelium (d-PAS and Alcian blue positive) may be flat, or form small papillary or polypoid projections. Crypt-like invagination also can be seen. Various changes such as pseudo-pyloric, gastric foveolar, small and large intestinal, and squamous differentiation can be found. Immunohistochemical studies will demonstrate the presence of scattered neuroendocrine cells. [1] [2] [3] 12 The epithelium may be display various degrees of dysplasia ranging from adenoma to borderline to noninvasive and invasive carcinoma. 6 In MCN adenoma, the epithelium shows basally located nuclei with no increase in mitosis. In the borderline lesion, the epithelium may exhibit papillary projections or crypt-like invagination, some nuclear pseudostratification with crowding and slightly enlarged nuclei. Mitoses can be observed.
Mucinous cystadenocarcinoma can either be invasive or noninvasive. Noninvasive MCN demonstrates high-grade dysplastic epithelial changes which are usually focal and may be detected only after reviewing multiple sections. The epithelium often forms papillae and irregular budding, as well as branching with nuclear stratification, severe nuclear atypia, and frequent mitoses.
Invasive mucinous cystadenocarcinoma usually demonstrates an invasive component similar to common ductal adenocarcinoma. In some cases, invasive adenosquamous carcinoma, osteoclast-like giant cell carcinoma, or choriocarcinoma have been reported. 3, 4, 7, 13 The ovarian stroma is composed of densely packed spindle-shaped cells with elongated nuclei and sparse cytoplasm. It may show evidence of luteinization characterized by the presence of clusters or single epithelial cells with round to oval nuclei and abundant clear cytoplasm. Stromal luteinization is found in decreasing order from adenomatous to carcinomatous cases. 13 When the tumors are large, the stroma may be markedly fibrotic and hypocellular, and the spindleshaped cells may be difficult to identify. Rarely, mural nodules with sarcomatous stroma or an associated sarcoma can be seen. 9, 11, 13 Immunohistochemical phenotype:
The epithelial component is positive for various epithelial markers, including CEA and cytokeratins 7, 8, 18, and 19. 12 The stromal component expresses vimentin and alpha smooth muscle actin and in a high proportion, progesterone and estrogen receptors. 13 Luteinized cells, when present, are immunolabeled with calretinin (which recognizes testicular Leydig cells and hilar ovarian cells) and inhibin (marker of sex cord-stromal differentiation). 13, 15 Prognosis:
Regardless of the degree of cellular atypia, the prognosis of MCN (noninvasive) is excellent if completely removed. 3, 10, 13 The prognosis of invasive mucinous cystadenocarcinoma depends on the extent of the tumor, with poor outcome correlating with the amount of invasion of the tumor wall and peritumoral tissues. 13 Patients older than 50 years have been reported to have a lower survival rate. 13 
SOLID PSEUDOPAPILLARY NEOPLASMS Definition, Epidemiology and Etiology:
Solid pseudopapillary neoplasms (SPNs) are usually benign neoplasms with a predilection for young women. They are composed of monomorphic cells forming loose solid sheets and pseudopapillary structures. Various synonyms can be found in the literature, such as "solid and cystic," "papillary cystic," and also "solid and papillary epithelial" neoplasm. 1, 6 SPNs have been recognized with increasing frequency in recent years. They account for approximately 1 to 2% of all exocrine pancreatic tumors and about 10% of cystic pancreatic neoplasm. 3, 7, 9 Predominantly recognized in adolescent girls and young women (mean age 35 years, range 8 to 67), SPNs can be recognized in the same age range in male patients, but much more rarely. 8, 15 The etiology of this neoplasm is unknown, although the striking differences in sex and age distribution point to genetic and hormonal factors.
Clinical Characteristics:
The presenting symptoms of SPNs are nonspecific, and usually the neoplasms are found incidentally. Rarely, they cause abdominal discomfort and pain. Jaundice is uncommon. 10, 11 Imaging studies usually reveal a sharply demarcated lesion which is either solid or solid and cystic without internal septation. 2 . Sometimes calcification can be noted at the tumor margin. Angiographic studies reveal either a hypovascular or mildly hypervascular lesion with displacement of surrounding vessels. 17
Gross Pathology:
SPNs invariably present as round large solitary masses. The tumor ranges between 3 and 18 cm in diameter, the average size between 8 and 10 cm. 4 Multiple tumors are rare. 11 On cross-section, the surface either reveals lobulated light brown areas, but more frequently, large zones of necrosis and hemorrhage with cystic spaces filled with necrotic debris. On occasion, the lesion is entirely hemorrhagic and cystic, mimicking a pseudocyst. 4 Invasion of adjacent organs or the portal vein have been reported rarely. [12] [13] [14] Histopathology:
In the absence of significant necrosis, SPNs usually exhibit a solid monomorphic pattern with variable sclerosis, although more frequently pseudopapillary proliferation (secondary to vascular ischemic damage) lined by small monomorphic cells is seen. The neoplastic cells usually have an eosinophilic cytoplasm, although a clear vacuolar cytoplasm also has been reported. Generally, d-PAS resistant globules of various size can be seen. Characteristically, the oval to round nuclei have a finely dispersed chromatin and are often grooved. Mitoses are rare and if numerous may indicate a poor behavior (see below). The space between pseudopapillary structures is filled by hemorrhage and scattered areas of hyalinized fibrosis with or without calcification, and cholesterol clefts can be seen. 4
Immunohistochemistry:
The cells of SPNs are consistently positive for alpha 1-antitrypsin and alpha 1-antichymotrypsin, as well as NSE, vimentin, and progesterone receptors. Of note, the positivity for alpha 1-antitrypsin and alpha 1-antichymotrypsin, although intense, usually involves small cell clusters or single cells. In contrast, NSE and vimentin are usually diffuse. In addition, the nuclei are also consistently strongly positive for beta-catenin, a reflection of the biology of the tumor. Inconsistent results have been reported for synaptophysin, CA19.9, and cytokeratin, which is detected in 30 to 70% of the cases. 4, 5 Prognosis:
In the majority of cases; the prognosis of SPN is extremely good. After complete resection, over 95% of patients are cured. Even if present, local spread or dissemination to the peritoneum or even hepatic metastasis are not inconsistent with a relatively indolent course with patients experiencing long disease-free periods. 4, 5, 16 However, there have been reports of patients with a dismal prognosis. The histologic features associated with a poor prognosis include
